NCT00601315View on ClinicalTrials.gov

Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Infection
Interventions
DRUG

Clarithromycin

Trial Locations (1)

85044-5318

MDS Pharma Services, Phoenix

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00601315 - Bioequivalency Study of Clarithromycin Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter